Down-regulation of E-cadherin is shown to be important for breast cancer metastasis and may reflect the progression and metastasis in breast cancer associated with poor prognosis (Lambert et al. 2017; Onder et al. 2008). This evidence concerns the gene CDH1 and breast carcinoma.